Streetbeat News

Stock Prices

GRTX

Galera Therapeutics has received a Complete Response Letter from the FDA for avasopasem manganese, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:53 pm

ZIMV

ZimVie announced that it has received FDA approval for its new Mobi-C implant, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:51 pm

DDD

Credit Suisse analyst Shannon Cross has maintained an 'Underperform' rating on 3D Systems (NYSE:DDD) and lowered the price target from $7 to $6.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:51 pm

TASK

TaskUs has issued Q3 and FY23 revenue guidance below estimates, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:50 pm

ATNF

180 Life Sciences has announced the pricing of its $3M public offering of 4,615,385 shares at $0.65 per share.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:49 pm

SPY

UUP

The US Consumer Price Index (CPI) rose 3.2% in July 2023, below the expected 3.3%, easing concerns about Federal Reserve interest rate hikes. Core inflation fell from 4.8% to 4.7% YoY. The Labor Department reported an increase in initial jobless claims for the week ending Aug. 5, from 227,000 to 248,000. The dollar and Treasury yields declined, while S&P 500 and Nasdaq 100 futures rose. The Invesco DB USD Index Bullish Fund ETF (UUP) and the SPDR S&P 500 ETF Trust (SPY) were directly affected.

Portfolio Pulse from Piero Cingari

August 10, 2023 | 12:47 pm

STKL

SunOpta reported a year-over-year decrease in Q2 adjusted EPS results and worse-than-expected Q2 sales results. The company also cut its FY23 revenue outlook below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:47 pm

ADTN

ENB

FSR

MDT

MRVL

ORCL

PEG

Jim Cramer, host of CNBC's 'Mad Money Lightning Round', has given his views on several stocks. He recommends buying Enbridge Inc. (ENB) for its double yield and Oracle Corporation (ORCL), referring to it as 'in the bullpen'. He advises keeping Medtronic plc (MDT) small as he prefers GE Healthcare. He does not recommend ADTRAN Holdings, Inc. (ADTN) due to its losses, Fisker Inc. (FSR) which he refers to as 'more of a charity', and Marvell Technology, Inc. (MRVL) at its current price. He also mentions Public Service Enterprise Group Incorporated (PEG) as a solid company with a good yield.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 12:47 pm

APP

Applovin Corp (NASDAQ:APP) reported better-than-expected Q2 financial results, with revenues of $750.16 million and EPS of 22 cents, beating estimates. The company's software revenue increased by 28% YoY, while apps revenue fell by 25%. The strong results were attributed to the successful launch of its latest AI-based advertising engine. The company ended the quarter with $876 million in cash and equivalents. Applovin expects Q3 revenue to be between $780 million and $800 million, higher than estimates.

Portfolio Pulse from Adam Eckert

August 10, 2023 | 12:46 pm

INVZ

Innoviz Technologies Ltd (NASDAQ:INVZ) has commenced an underwritten public offering of 26 million of its ordinary shares at a price of $2.50 per share, with an option for underwriters to buy up to 3.9 million additional shares. The gross proceeds are expected to total $65 million, which will be used for general corporate purposes. The offering is expected to close on Aug. 14. Innoviz shares are down 20% since the start of the year.

Portfolio Pulse from Adam Eckert

August 10, 2023 | 12:44 pm